Medical Data Collection Sample Work
The objective outlined in this essay is to investigate the condition of interstitial cystitis as a study topic, develop a research question and project goal, and explain three potential methodologies. The gathering and administration of data collection peer-reviewed scientific article
Remember, Medical Data Collections aims to ensure the quality and validity of the research. It’s essential to approach the process with an objective mindset and Pubrica provide constructive feedback to help improve the Manuscript.
A data collection plan for an intravesical therapy outcome study
This sample is a methodology essay that plans how data will be collected for a small clinical study: whether Uracyst instillations improve quality of life in patients with interstitial cystitis (IC). It is written from the perspective of nursing staff running an outpatient instillation clinic. It sets a research aim and objective, compares three data collection methods, chooses one, and covers consent, ethics and practical limitations. It ends with the patient questionnaire and a reference list. Nursing and allied health students writing research proposals, and clinicians planning service-based outcome studies, are the intended readers.
Interstitial cystitis and why validated symptom scores matter
Interstitial cystitis, also called bladder pain syndrome, is a chronic condition with bladder pain, urgency, frequency and nocturia, and it is diagnosed largely by excluding other causes. Uracyst is a 2% chondroitin sulfate solution instilled into the bladder, according to the manufacturer source in the sample's references. Because the condition's effects are mostly subjective, the plan measures outcomes with the O'Leary–Sant Interstitial Cystitis Symptom Index, which it quotes as a valid, reliable and responsive measure of symptom change. It also cites Kushner and Moldwin (2006), who concluded that such questionnaires should not be used to define IC but can be used to screen symptomatic patients and to follow those already diagnosed. That supports their use as an outcome measure in this plan.
Aim, objectives and the five O'Leary–Sant end points
The aim is to compare quality of life before and after treatment using each patient's symptom scores. The objective sets the time points at week 1 and week 24. Five questions are to be answered with the O'Leary–Sant score: whether urgency, frequency, nocturia, and pain or burning improve over 24 weeks, and whether specific lifestyle changes improve symptoms and daily life. The design is quantitative and longitudinal. Three nursing professionals will collect the data, and the essay argues that numerical scores keep the analysis objective across them. Random sampling is proposed so that every eligible patient has an equal chance of inclusion. The essay also says it will apply a situational perspective, which it describes as little used in the IC and painful bladder syndrome literature, to explain how symptoms differ between patients.
Observation, interview or questionnaire: how the plan chooses
| Method | Strengths noted | Drawbacks noted |
|---|---|---|
| Structured observation | Reliable, repeatable, quick numerical results | Not feasible to observe every patient after treatment in clinic time; people may behave differently when watched |
| Structured interview | Simple; every participant answers the same questions in the same order | Inflexible; hard to capture a true picture of the person or quantify outcomes after treatment |
| Structured questionnaire (chosen) | Cost-effective, easy to control, quick to analyse by computer; patients can answer without time pressure | Depends on honest, complete self-report |
The questionnaire in the appendix has four sections: general improvement, symptoms, how much the condition is a problem, and pain. Pain is recorded on visual analogue lines at weeks 1, 10 and 24.
Consent, ethics and practical risks to data quality
The plan defines informed consent using Parahoo (2006), as cited by the Royal College of Nursing: agreeing to take part on the basis of accessible information about risks and benefits. It requires approval from the appropriate research ethics committee. It also lists honestly the problems that could compromise the data:
- only two outpatient sessions a week, and gaps in analysis during annual leave;
- urinary tract infections that pause instillations;
- questionnaires completed by someone other than the patient, or left incomplete;
- poor adherence to lifestyle advice;
- missed weekly appointments that break the treatment cycle.
Strengthening the design before the first questionnaire
A reviewer would suggest some refinements. A before-and-after design without a comparison group cannot separate the effect of the drug from natural fluctuation or regression to the mean, so this limitation should be stated and, if possible, addressed. The plan would also benefit from a sample size estimate, a clear account of how random selection works within one clinic, a pre-specified paired analysis, and a data protection statement.
Pubrica's experimental design service helps refine plans like this. Analysis plans and sample size calculations are available through biostatistics support, and background evidence can be gathered through literature search and citation support. This page is a research-methods sample, not treatment advice for bladder pain.
Questions about this sample
Why does the plan use the O'Leary–Sant score?
The O'Leary–Sant Interstitial Cystitis Symptom Index is a validated questionnaire that measures change in urgency, frequency, nocturia and bladder pain. The sample cites evidence that it is valid, reliable and responsive, so it suits comparing symptoms at week 1 and week 24 of Uracyst treatment in the same patients.
Why was a questionnaire chosen over observation or interviews?
The essay judges structured observation impractical in a busy outpatient clinic and liable to change behaviour, and finds structured interviews too rigid to capture meaningful outcomes. Questionnaires are cheap, easy to administer at each visit and quick to analyse, and patients can complete them without time pressure.
What could undermine the quality of the data?
The plan names several risks: limited clinic sessions and staff leave, urinary tract infections that pause treatment, questionnaires completed by someone else or left incomplete, poor adherence to lifestyle advice, and missed weekly appointments. Each could produce missing or misleading scores at the week 24 comparison.
Can a before-and-after design show that Uracyst works?
It can show whether symptom scores changed over 24 weeks, but without a comparison group it cannot prove the drug caused the change. Natural variation in symptoms and regression to the mean could explain part of any improvement, so a stronger study would add a control arm or interpret results cautiously.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
